
Guidelines for healthcare practitioners to discover and manage patients with hoarseness, also known as dysphonia, have been released by the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF). The guidelines will be the first-and only-national clinical practice guideline for hoarseness.
The guidelines would be stressing upon evidence-based hoarseness management by clinicians besides educating patients on the prevalence of the common vocal health complication.
From Sciencedaily.com:
Key features of the new guideline include:* Most, but not all, hoarseness is the result of benign underlying or self-limiting factors; however, clinicians should consider the possibility of a serious underlying condition (growth or tumor of the larynx) or medication side effects as a cause.* Laryngoscopy is an office procedure to visualize the larynx (voice box and vocal cords) that should be performed if hoarseness persists or if the cause is uncertain.* Imaging studies, such as a CT or MRI scans, should not be obtained for a primary complaint of hoarseness prior to visualizing the larynx; laryngoscopy is the primary diagnostic modality and should be done first.* Anti-reflux medicines should not be prescribed for hoarseness unless there are (a) signs or symptoms of gastroesophageal reflex disease (GERD), such as heartburn or regurgitation, or (b) signs of inflammation of the larynx seen during laryngoscopy.* Steroids or antibiotics given by mouth are not recommended for hoarseness and should not be used routinely.
Richard M. Rosenfeld, MD, MPH, an author of the guideline and chair of the AAO-HNSF Guideline Development Task Force, remarked that hoarseness affects approximately 20 million people in the U.S. alone at any given time.